- Home
- VOR vs FORA Comparison
VOR vs FORA Comparison
Compare VOR & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- FORA
- Stock Information
- Founded
- VOR 2015
- FORA 2014
- Country
- VOR United States
- FORA United States
- Employees
- VOR N/A
- FORA N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- FORA Computer Software: Prepackaged Software
- Sector
- VOR Health Care
- FORA Technology
- Exchange
- VOR Nasdaq
- FORA Nasdaq
- Market Cap
- VOR 57.1M
- FORA 62.8M
- IPO Year
- VOR 2021
- FORA N/A
- Fundamental
- Price
- VOR $0.87
- FORA $2.12
- Analyst Decision
- VOR Strong Buy
- FORA Strong Buy
- Analyst Count
- VOR 7
- FORA 1
- Target Price
- VOR $11.36
- FORA $5.00
- AVG Volume (30 Days)
- VOR 577.8K
- FORA 12.8K
- Earning Date
- VOR 11-07-2024
- FORA 11-13-2024
- Dividend Yield
- VOR N/A
- FORA N/A
- EPS Growth
- VOR N/A
- FORA N/A
- EPS
- VOR N/A
- FORA N/A
- Revenue
- VOR N/A
- FORA $19,709,723.00
- Revenue This Year
- VOR N/A
- FORA N/A
- Revenue Next Year
- VOR N/A
- FORA $13.59
- P/E Ratio
- VOR N/A
- FORA N/A
- Revenue Growth
- VOR N/A
- FORA N/A
- 52 Week Low
- VOR $0.63
- FORA $1.97
- 52 Week High
- VOR $3.14
- FORA $4.15
- Technical
- Relative Strength Index (RSI)
- VOR 47.17
- FORA 56.69
- Support Level
- VOR $0.83
- FORA $1.97
- Resistance Level
- VOR $1.10
- FORA $2.05
- Average True Range (ATR)
- VOR 0.10
- FORA 0.06
- MACD
- VOR -0.01
- FORA 0.00
- Stochastic Oscillator
- VOR 22.43
- FORA 100.00
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.